General Information of Drug (ID: DM3DBZY)

Drug Name
JNJ-61178104
Indication
Disease Entry ICD 11 Status REF
Autoimmune disease 4A40-4A45 Phase 1 [1]
Cross-matching ID
TTD ID
D05AVL

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)